No Data
No Data
Curis to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2025
Truist Financial Maintains Curis(CRIS.US) With Buy Rating
Truist Removes Price Target on Curis Due to Volatility, Low Share Price; Price Target Was $26, Buy Rating Kept
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Upgrade: Analysts Just Made A Meaningful Increase To Their Curis, Inc. (NASDAQ:CRIS) Forecasts
H.C. Wainwright Maintains Curis(CRIS.US) With Buy Rating, Maintains Target Price $16